254 related articles for article (PubMed ID: 12731665)
1. Recent developments in hematopoietic stem cell transplantation for multiple myeloma.
Bensinger WI
Int J Hematol; 2003 Apr; 77(3):232-8. PubMed ID: 12731665
[TBL] [Abstract][Full Text] [Related]
2. The current status of hematopoietic stem cell transplantation for multiple myeloma.
Bensinger WI
Clin Adv Hematol Oncol; 2004 Jan; 2(1):46-52. PubMed ID: 16163159
[TBL] [Abstract][Full Text] [Related]
3. The role of hematopoietic stem cell transplantation in the treatment of multiple myeloma.
Bensinger WI
J Natl Compr Canc Netw; 2004 Jul; 2(4):371-8. PubMed ID: 19795599
[TBL] [Abstract][Full Text] [Related]
4. The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma.
Bensinger WI
Leukemia; 2006 Oct; 20(10):1683-9. PubMed ID: 16888617
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation for multiple myeloma.
Bensinger WI
Biomed Pharmacother; 2002 May; 56(3):133-8. PubMed ID: 12046684
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation for multiple myeloma.
Bensinger WI; Maloney D; Storb R
Semin Hematol; 2001 Jul; 38(3):243-9. PubMed ID: 11486312
[TBL] [Abstract][Full Text] [Related]
7. Is there still a role for allogeneic stem-cell transplantation in multiple myeloma?
Bensinger WI
Best Pract Res Clin Haematol; 2007 Dec; 20(4):783-95. PubMed ID: 18070719
[TBL] [Abstract][Full Text] [Related]
8. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
9. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
Nishihori T; Alsina M
Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244
[TBL] [Abstract][Full Text] [Related]
10. Progress in hematopoietic stem cell transplantation in multiple myeloma.
Gahrton G
Curr Opin Hematol; 2005 Nov; 12(6):463-70. PubMed ID: 16217163
[TBL] [Abstract][Full Text] [Related]
11. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
12. Reduced intensity allogeneic stem cell transplantation in multiple myeloma.
Bensinger WI
Front Biosci; 2007 May; 12():4384-92. PubMed ID: 17485382
[TBL] [Abstract][Full Text] [Related]
13. Reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma: a concise review.
Salit RB; Bishop MR
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):247-52. PubMed ID: 21658650
[TBL] [Abstract][Full Text] [Related]
14. Role of reduced intensity conditioning in allogeneic hematopoietic cell transplantation for patients with multiple myeloma.
Nishihori T; Kharfan-Dabaja MA; Ochoa-Bayona JL; Bazarbachi A; Pasquini M; Alsina M
Hematol Oncol Stem Cell Ther; 2011; 4(1):1-9. PubMed ID: 21460601
[TBL] [Abstract][Full Text] [Related]
15. Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic.
Mir MA; Kapoor P; Kumar S; Pandey S; Dispenzieri A; Lacy MQ; Dingli D; Hogan W; Buadi F; Hayman S; Gandhi M; Gertz MA
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):349-357.e2. PubMed ID: 25958193
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care.
Koehne G; Giralt S
Curr Opin Oncol; 2012 Nov; 24(6):720-6. PubMed ID: 22960558
[TBL] [Abstract][Full Text] [Related]
17. Treatment of multiple myeloma.
San Miguel JF; Bladé Creixenti J; García-Sanz R
Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation for multiple myeloma.
Bensinger W
Hematol Oncol Clin North Am; 2014 Oct; 28(5):891-902. PubMed ID: 25212888
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation and targeted immunotherapy for multiple myeloma.
Danylesko I; Shimoni A; Nagler A
Clin Lymphoma Myeloma Leuk; 2013 Sep; 13 Suppl 2():S330-48. PubMed ID: 24290219
[TBL] [Abstract][Full Text] [Related]
20. The graft-versus-myeloma effect: chronic graft-versus-host disease but not acute graft-versus-host disease prolongs survival in patients with multiple myeloma receiving allogeneic transplantation.
Donato ML; Siegel DS; Vesole DH; McKiernan P; Nyirenda T; Pecora AL; Baker M; Goldberg SL; Mato A; Goy A; Rowley SD
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1211-6. PubMed ID: 24792872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
